文献速递青光眼

丝裂霉素C增强小梁切除术:眼球筋膜下注射与浸泡海绵法的随机临床试验

Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial.
PubMed 文献 · Br J Ophthalmol · 2017-01-18

这项多中心随机临床试验将80例连续开角型青光眼病例随机分为两组,分别接受眼球筋膜下注射0.1 mL 0.01%丝裂霉素C(MMC)与0.02% MMC浸泡海绵,比较小梁切除术的疗效与安全性。两组末次随访眼压均显著下降,完全成功率均为82.5%,组1滤过泡更弥漫、血管更少且更浅,内皮细胞计数无显著变化。作者认为眼球筋膜下注射MMC是传统浸泡海绵法的安全有效替代方案,可产生更有利的滤过泡形态。

要点

  • 两组末次随访眼压均较术前显著下降,完全成功率均为82.5%。
  • 组1第6个月滤过泡更弥漫、血管更少且更浅,差异有统计学意义。
  • 末次随访内皮细胞计数无显著变化(p=0.813)。

核心结论

  • 作者认为眼球筋膜下注射MMC是传统浸泡海绵法的安全有效替代方案。
  • 作者认为该方法在小梁切除术后产生更有利的滤过泡形态。

研究设计与样本

  • 多中心随机临床试验,纳入80例连续开角型青光眼病例,随机分为两组。
  • 组1接受眼球筋膜下注射0.1 mL 0.01% MMC,组2接受0.02% MMC浸泡海绵。
  • 主要结局为眼压,次要结局为内皮细胞计数变化及按Indiana滤过泡外观分级量表评估的滤过泡形态。
  • 结局指标于术后1、3、6个月比较。
  • 完全成功定义为第6个月眼压6-15 mm Hg且不用药,条件成功定义为第6个月眼压6-15 mm Hg且用药。

主要发现

  • 组1术前平均眼压21.8±5.1 mm Hg,末次随访降至10.3±3.7 mm Hg(p<0.001)。
  • 组2术前平均眼压21.8±5 mm Hg,末次随访降至10.8±3.5 mm Hg(p<0.001)。
  • 完全成功率两组均为82.5%,条件成功率组1为0、组2为2.5%(p=0.316)。
  • 第6个月组1滤过泡趋于更弥漫、血管更少且更浅(p=0.45、<0.001和<0.007)。
  • 末次随访内皮细胞计数无显著变化(p=0.813)。

关键数值与推荐

  • 完全成功:第6个月眼压6-15 mm Hg且不用药;条件成功:第6个月眼压6-15 mm Hg且用药。
  • 组1完全成功率82.5%,组2完全成功率82.5%。
  • 组1条件成功率0,组2条件成功率2.5%(p=0.316)。

临床怎么用

  • 作者认为眼球筋膜下注射MMC可作为传统浸泡海绵法的安全有效替代方案。
  • 作者认为该注射方法在小梁切除术后产生更有利的滤过泡形态。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To compare the efficacy and safety of subtenon injection of mitomycin C (MMC) with that of conventional application of MMC-soaked sponges in trabeculectomy. METHODS: In this multicentre randomised clinical trial, 80 consecutive open-angle glaucoma cases were randomised into two groups; group 1 received a subtenon injection of 0.1 mL of 0.01% MMC, while group 2 received 0.02% MMC-soaked sponges. Primary outcome measure was intraocular pressure (IOP), and secondary outcome measures were endothelial cell count (ECC) changes and bleb morphology according to the Indiana Bleb Appearance Grading Scale. Outcome measures were compared at 1, 3 and 6 months postoperatively. Complete and qualified success was defined as IOP within 6-15 mm Hg without and with medications at month 6, respectively. RESULTS: Mean preoperative IOP was 21.8±5.1 in group 1, which reduced to 10.3±3.7 mm Hg at final visit (p<0.001). Corresponding values for group 2 were 21.8±5 and 10.8±3.5 mm Hg respectively (p<0.001). Complete success was 82.5% in both groups, and qualified success was 0 and 2.5% in groups 1 and 2, respectively. (p=0.316) The blebs tended to be more diffuse, less vascularised and shallower in group 1, at month 6 (p=0.45,<0.001 and <0.007 respectively). ECCs did not change significantly at final visit (p=0.813). CONCLUSIONS: Subtenon injection of MMC is a safe and effective alternative to the conventional soaked sponge method. This method produces more favourable bleb morphology after trabeculectomy. TRIAL REGISTRATION NUMBER: NCT02385370, Post-results.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Pakravan M, Esfandiari H, Yazdani S, et al. Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial. Br J Ophthalmol. 2017. PMID: 28100482. doi:10.1136/bjophthalmol-2016-309671

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。